SLC6A13 and type 2 diabetes mellitus: We used the Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal to understand the effect of missense mutations in genes encoding the hepatic GABA transporters (SLC6A6, SLC6A8, SLC6A12, and SLC6A13).